Case Details
- Citation: [2023] SGHC 156
- Title: Dr Who Waterworks Pte Ltd and others v Dr Who (M) Sdn Bhd and others
- Court: High Court of the Republic of Singapore (General Division)
- Date of Decision: 26 May 2023
- Suit No: Suit No 600 of 2020 (consolidated with Suit No 96 of 2021)
- Judge(s): Dedar Singh Gill J
- Hearing Dates: 6–8 September 2022; 14 November 2022
- Judgment Reserved: Yes
- Plaintiff/Applicant(s): Dr Who Waterworks Pte Ltd (formerly known as Cana Services Pte Ltd); Dr Who Global Watertech (S) Pte Ltd; Dr Who Laboratories (S) Pte Ltd (formerly known as New Global Fluid Engineering & Machinery Pte Ltd)
- Defendant/Respondent(s): Dr Who (M) Sdn Bhd; Oo Tim Wee; Low Siew Eng; Dynamic Watermedia Pte Ltd (formerly known as Dr Who (S) Pte Ltd)
- Plaintiffs in Counterclaim: Dr Who (M) Sdn Bhd; Oo Tim Wee; Low Siew Eng; Dynamic Watermedia Pte Ltd (formerly known as Dr Who (S) Pte Ltd)
- Defendants in Counterclaim: Dr Who Waterworks Pte Ltd (formerly known as Cana Services Pte Ltd); Dr Who Global Watertech (S) Pte Ltd; Dr Who Laboratories (S) Pte Ltd (formerly known as New Global Fluid Engineering & Machinery Pte Ltd); Koh Tiong Gee (Xu Zhongyi); Tan Kim Peng
- Legal Areas: Intellectual Property (trade marks and trade names); Contract (breach); Tort (conspiracy); Tort (detinue)
- Statutes Referenced: Companies Act
- Cases Cited: [2023] SGHC 156 (as provided in metadata)
- Judgment Length: 130 pages; 33,798 words
Summary
In Dr Who Waterworks Pte Ltd and others v Dr Who (M) Sdn Bhd and others [2023] SGHC 156, the High Court was faced with a multi-layered dispute arising from the breakdown of a long commercial relationship between related Singapore and Malaysian entities operating in the bottled water and water dispenser ecosystem. The plaintiffs (Singapore-based companies) alleged that the defendants used signs associated with the plaintiffs’ “DR. WHO” branding—across commercial vehicles, product cartons, websites, and social media—in a manner that infringed the plaintiffs’ trade marks and amounted to passing off. The plaintiffs also advanced contractual and tortious claims, including breach of a deed and conspiracy to injure.
The defendants, in turn, mounted counterclaims that included allegations of breach of the deed by the plaintiffs, conspiracy to injure by the plaintiffs, non-payment for goods supplied, and wrongful interference with the defendants’ business. The judgment, delivered by Dedar Singh Gill J, addressed the parties’ competing narratives about the origin and ownership of the “DR. WHO” branding, the scope and effect of the parties’ deed arrangements, and whether the defendants’ post-breakdown conduct created the requisite legal risk of confusion or misrepresentation for trade mark infringement and passing off.
Although the extract provided is truncated, the structure of the judgment and the issues identified show that the court conducted a claim-by-claim analysis: trade mark infringement (including specific sign usages and specific channels such as cartons sold at IKEA and website meta-title tags), passing off (goodwill, misrepresentation, and damage), breach of deed, conspiracy to injure, and wrongful detention of labels. The court’s approach reflects Singapore’s doctrinal framework for IP claims—particularly the “identity/similarity of signs”, “identity/similarity of goods”, and “likelihood of confusion” analysis—alongside contract interpretation and tort principles for conspiracy and related wrongs.
What Were the Facts of This Case?
The plaintiffs were three Singapore companies associated with the “DR. WHO” branding. The first plaintiff, Dr Who Waterworks Pte Ltd, was incorporated on 19 February 1998 and later changed its name to “Dr. Who Waterworks Pte Ltd” on 26 September 2002. The court accepted that the first plaintiff was engaged in the supply of 5-gallon bottled water and the leasing and placement of water dispensers. In 2003, the first plaintiff expanded into providing bottled water bearing customers’ marks—bottles supplied in various sizes and bearing personalised branding. The second plaintiff, Dr Who Global Watertech (S) Pte Ltd, was incorporated by Mr Koh on 27 June 2007 and took over the segment of supplying and distributing bottled water bearing customers’ marks. The third plaintiff, Dr Who Laboratories (S) Pte Ltd, was incorporated in 2008 for research and development and later supported other business segments, including direct piping.
On the Malaysian side, the first defendant, Dr Who (M) Sdn Bhd, was incorporated in Malaysia on 11 April 2007 by the second defendant, Oo Tim Wee. The court described its business as dealing in mineral and aerated water and providing integrated logistics services. The initial shareholders included Mr Oo, Ms Low Siew Eng, Mr Koh, Ms Tan Kim Peng, and the first plaintiff, though the first plaintiff later sold its shareholding to the remaining shareholders. The fourth defendant, Dynamic Watermedia Pte Ltd (formerly Dr Who (S) Pte Ltd), was incorporated in Singapore on 17 July 2019 by Mr Oo and Ms Low, with them as the only directors at incorporation.
The dispute’s origins lay in the parties’ earlier collaboration and then a breakdown. A key factual battleground was the genesis of the “DR. WHO” name and branding. Mr Koh testified that he conceived the “DR. WHO” name around the time of the first plaintiff’s name change in September 2002, describing “DR” as evoking “the usual doctor’s advice to drink plenty of water” and “WHO” as an abbreviation of the World Health Organisation. The defendants disputed this, contending that the name was created by prior owners before Mr Koh joined as a shareholder. This dispute mattered because it fed into the plaintiffs’ claims of ownership and goodwill, and the defendants’ counter-narrative about legitimacy and entitlement to use the branding.
Commercially, the relationship developed through manufacturing and supply arrangements. After the first plaintiff’s name change, Mr Koh became acquainted with Mr Oo. At that time, Mr Oo operated APlus Water & System Sdn Bhd, which manufactured and supplied bottled water and dispenser services. The first plaintiff engaged APlus Water for supply and manufacturing services. The court also noted that the bottled water bearing customers’ marks was manufactured and supplied by APlus Water from November 2002 to December 2011, and later transferred to another company owned by Mr Oo and his brother. In 2004, Mr Koh acquired majority shareholding in the first plaintiff after share transfers from Mr Oo and Mr Chan. These facts formed the backdrop to the later deed-based arrangements and the eventual acrimonious breakdown.
What Were the Key Legal Issues?
The judgment addressed multiple legal issues across intellectual property, contract, and tort. The first major cluster concerned trade mark infringement and passing off. For infringement, the court had to determine whether the defendants’ use of particular signs—such as the “DR. WHO quatrefoil device” and website signs including “www.drwho.com.my” and “www.drwho.asia”—fell within the scope of the plaintiffs’ trade mark rights. This required analysis of (i) identity or similarity of the signs used, (ii) identity or similarity of the goods or services, and (iii) likelihood of confusion.
For passing off, the court had to assess whether the plaintiffs possessed goodwill in their identifiers, whether the defendants made misrepresentations to the relevant public that caused or were likely to cause confusion, and whether damage resulted or was likely. The judgment’s outline indicates that the court examined misrepresentation in multiple contexts: signs on cartons sold at IKEA Alexandra and IKEA Tampines, signs on websites, signs on the defendants’ Facebook page, and the use of the corporate name “DR. WHO (S) PTE LTD”, as well as signs on commercial vehicles.
Beyond IP, the court had to decide contractual and tortious claims. The plaintiffs alleged breach of a deed by the defendants. They also alleged unlawful conspiracy to injure and wrongful detention of labels by the defendants. The defendants’ counterclaims mirrored these themes: breach of the deed by the plaintiffs, conspiracy to injure by the plaintiffs, non-payment for goods supplied, and wrongful interference with the defendants’ business. These issues required the court to interpret the deed’s obligations and to apply the elements of conspiracy and related tort doctrines.
How Did the Court Analyse the Issues?
The court’s analysis followed a structured approach consistent with Singapore IP jurisprudence. For trade mark infringement, the court examined each alleged infringing use separately. The outline shows that the court considered the use of allegedly infringing signs on commercial vehicles and driver attire (including “Identity/Similarity of the signs used” and “Likelihood of confusion”), the use of signs on cartons sold at IKEA, the use of website signs (including meta-title signs), and the use of signs on a Facebook page and the corporate name “DR WHO (S) Pte Ltd”. This claim-by-claim method is significant because it recognises that infringement and confusion are fact-sensitive: the same brand may be used in different contexts, and the relevant public’s perception may vary depending on the medium and presentation.
In assessing identity or similarity of signs, the court focused on the visual and conceptual features of the “DR. WHO” branding. The outline specifically references the “DR. WHO quatrefoil device sign” and the “www.drwho.com.my” sign, and it indicates that the court compared those signs to the plaintiffs’ trade mark(s). The court also analysed the identity or similarity of goods. In trade mark infringement disputes, this step is not merely formal; it requires the court to consider whether the defendants’ goods or services are the same as, or closely related to, those for which the plaintiffs’ marks are registered or used in commerce. The judgment’s attention to cartons and websites suggests that the court treated the relevant goods as bottled water and related distribution/branding services, and it evaluated whether the defendants’ products were marketed in a way that would likely be associated with the plaintiffs.
Likelihood of confusion was central. The court’s outline indicates that it assessed confusion in each context, including the commercial vehicles and driver attire, the cartons sold at IKEA, and the websites. In practice, this involves considering how the relevant consumer would encounter the sign, the overall impression created by the sign, and whether the sign would lead consumers to believe there is a commercial connection, endorsement, or origin from the plaintiffs. The court’s separate treatment of website meta-title signs is particularly noteworthy: meta-title tags are not always visible in the same way as packaging or storefront signage, yet they can influence how search results and online listings present a brand. The court therefore had to evaluate whether such online presentation could still create confusion among the relevant public.
For passing off, the court’s analysis would have proceeded through the classic elements: goodwill, misrepresentation, and damage. The outline indicates that the court examined the “Distinctiveness of the plaintiffs’ identifiers” and the “Goodwill” associated with those identifiers. It then analysed misrepresentation giving rise to confusion or likelihood of confusion across the same channels as the infringement analysis: cartons, websites, Facebook page, commercial vehicles, and corporate name usage. This overlap demonstrates the court’s recognition that the same factual conduct may support both trade mark infringement and passing off, but the legal tests differ. Passing off is anchored in the protection of goodwill against deceptive conduct, whereas trade mark infringement is anchored in statutory rights and the likelihood of confusion under the trade mark regime.
On the contractual side, the deed’s role was pivotal. The plaintiffs alleged breach of the deed by the defendants, while the defendants counterclaimed breach by the plaintiffs. Although the extract does not include the deed’s text, the court’s outline shows that it treated the deed as a binding instrument governing post-breakdown conduct. The court would therefore have interpreted the deed’s terms, determined the parties’ obligations, and assessed whether the defendants’ conduct fell within any permitted uses or whether it breached restrictions (for example, restrictions on branding, labels, or competitive conduct). The inclusion of a claim for wrongful detention of labels suggests that the deed likely addressed ownership, custody, or use of physical branding materials.
For tortious conspiracy, the court would have applied the elements of unlawful conspiracy to injure, which in Singapore requires proof of an agreement between defendants to do an unlawful act or to do a lawful act by unlawful means, with the intention to injure the claimant. The outline indicates that the plaintiffs alleged unlawful conspiracy to injure, and the defendants counterclaimed conspiracy to injure by the plaintiffs. These mirrored allegations required the court to evaluate evidence of coordination, intention, and causation—particularly in a dispute where the parties were closely connected and the conduct spanned multiple jurisdictions and corporate structures.
What Was the Outcome?
The provided extract does not include the court’s final orders or the specific findings on each claim and counterclaim. However, the judgment’s detailed issue list and the “Summary of findings” sections for infringement and passing off indicate that the court reached determinations on each alleged infringing sign and each passing off context, and then moved to remedies. The structure also indicates that the court addressed breach of the deed, conspiracy to injure, and wrongful detention of labels, and then addressed the counterclaims in turn.
Practically, the outcome of such a case typically includes declarations of infringement/passing off (where established), injunctions restraining further use of infringing signs, orders relating to delivery up or destruction of infringing materials (particularly labels), and damages or account of profits where appropriate. The court’s separate “Remedies” sections for infringement and passing off suggest that it considered the appropriate remedial package for each cause of action, while the deed and tort findings would have influenced whether damages or other relief were granted on the contractual and tortious claims.
Why Does This Case Matter?
This decision is significant for practitioners because it illustrates how Singapore courts approach brand disputes that span multiple commercial channels and corporate entities. The court did not treat the “DR. WHO” branding as a single monolithic issue; instead, it analysed each alleged use—packaging, retail distribution, online presence, social media, and corporate naming—through the relevant legal tests. This is a useful template for litigators preparing infringement and passing off pleadings: the case demonstrates the importance of mapping each factual instance to the elements of the claim.
From an IP strategy perspective, the judgment also highlights the evidential and analytical value of breaking down “likelihood of confusion” across contexts. A sign used on cartons may create confusion differently from a sign used in website meta-title tags or in corporate names. For brand owners, this supports a comprehensive enforcement approach; for alleged infringers, it underscores the need to challenge not only similarity of signs but also the practical manner of market presentation and the perception of the relevant public.
Finally, the case matters beyond IP because it intertwines trade mark/passing off claims with contract and tort. Where parties have a deed governing branding materials and post-relationship conduct, the deed can become both a sword and a shield. The inclusion of conspiracy and wrongful detention claims shows that brand disputes can escalate into broader civil wrongs, especially where physical labels and branding assets are involved. Lawyers advising clients in similar cross-border or multi-entity brand arrangements should therefore consider both IP and contractual compliance risks, as well as potential tort exposure arising from coordinated conduct.
Legislation Referenced
- Companies Act (Singapore) (as referenced in the judgment metadata)
Cases Cited
- [2023] SGHC 156 (as provided in metadata)
Source Documents
This article analyses [2023] SGHC 156 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.